Navigation Links
Mild Asthma, a Revolutionary Therapy from Italian Research

Published by the New England Journal of Medicine the B.E.S.T study conducted in Italy

“TAKEN ONLY WHEN NEEDED AND THE DISEASE CAN BE CONTROLLED SUCCESSFULLY”

Prof. Fabbri: “Daily drug useless for mild persistent types affecting over one million 200 thousand people”. Chiesi’s commitment to pneumological research

MILAN, Italy, 29th May 2007 – Farewell to the daily dose of cortisone necessary for the control of mild persistent asthma: an Italian study has demonstrated that successful management of the disease is possible in the early stages without the need for daily maintenance therapy. A new “when needed” approach that may significantly improve the quality of life for one million 200 thousand Italians suffering from this disease. Amongst these sufferers there are also those suffering from allergic asthma, which is very common particularly at this time of year.

These are the results of a clinical study on BEST (BEclomethasone plus Salbutamol Treatment), published by the New England Journal of Medicine, one of the most prestigious international medical publications, sponsored by Chiesi Farmaceutici and the most important pneumological centres in Italy. “This is a revolutionary study – says research coordinator, Professor Leonardo Fabbri, Head of the Clinic for Respiratory Tract Diseases at the University of Modena and Reggio Emilia – as it questions a pivotal issue within the therapeutic programme for asthma in this group of patients. Our research has demonstrated that basic inhalant therapy with a preconstituted combination of a bronchodilator (salbutamol) and cortisone (beclometasone dipropionate), taken when symptoms first appear, allows clinical control similar to that provided by continuous daily inhalant therapy with cortisone plus bronchodilator when required, as recommended by current guidelines. Clinical research in Italy gains important international recogni
'"/>




Page: 1 2 3

Related medicine technology :

1. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
2. Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
3. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
4. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
8. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
9. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
10. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
11. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mild Asthma Revolutionary Therapy from Italian Research
(Date:11/24/2009)...ChindexInternational,Inc.,("Chindex")(Nasdaq: CHDX...althcareproductsandservicesinthePeople,sRepublicof...stAnnualPiperJaffray,"Unplugged"HealthCareConferen...el. , Managementiscurrentlyscheduledtopresent...-onemeetingsthroughouttheday.Awebcast,ofthepresent...
(Date:11/24/2009)...all/--Endologix,Inc.(Nasdaq: ELGX ),developerofmin...edtodaythatithasfiledamotiontostay,ordiscontinueal...againstitinOctober2009byCook,Inc.Themotionwasfiled...na. ,, Endologixhasrequestedthatthestayremainin...(USPTO)conductsproceedingstore-examinethetwopatent...
(Date:11/24/2009)...Call/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ)anno...losureStatementtoday,November24,2009,withtheUnited...ringtoconsiderapprovaloftheDisclosureStatementispr...theconfirmationofthePlanscheduledforJanuary7,2010....ll.ThePlanisexpected,ifapproved,toallowholdersofth...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Gene linked to increasingly common type of blood cancer 52171 1Gene linked to increasingly common type of blood cancer 52171 2Gene linked to increasingly common type of blood cancer 52171 3Practice makes perfect motor memory possible for neuroprosthetic control 13109 1Practice makes perfect motor memory possible for neuroprosthetic control 13109 2Practice makes perfect motor memory possible for neuroprosthetic control 13109 3Muscular protein bond strongest yet found in nature 13104 1Muscular protein bond strongest yet found in nature 13104 2
... different studies will report on use of ImmuKnow ... the International Society for Heart and Lung ... Md., April 9 Since it was initially cleared,as a...iated immunity (CMI),in immune-suppressed adult pa... of the Cylex(TM) ImmuKnow(R) assay (in clinical p...
... YORK, April 9, 2008 Intra-Cellular Therapies, In...m its ongoing development,programs for ITI-007, th...agonist/dopamine receptor phosphoprotein modulator...-007, which are in development for,schizophrenia a...emonstrate,ITI-007 has preclinical activity both i...
Other Medicine Technology:Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients 2Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients 3Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007 3
(Date:11/26/2009)...INCETON,N.J.,Nov.27/PRNewswire/--Thediabetespopula...yearsandannualmedicalspendingonthediseaseisproject...gtoastudypublishedintheDecemberissueof DiabetesCar...),aprogramofNovoNordisk,commissionedtheanalysisbya...heforecast,thenumberofAmericanslivingwithdiabetesw...
(Date:11/26/2009)... bigger thrill when on an emotional rollercoaster,...thDay News) -- Call it the fear factor meets the j... spectators -- especially those who root for the w...it,s a closely contested match and victory was in ...r. , Chew on that this Thanksgiving weekend as ...
(Date:11/26/2009)... Benton Communications announces a ...h system for retailers struggling to make an econo...ovember 26, 2009 -- Flu fears is the type of chall...mergency room, according to Dr. David Benton, busi...d business growth system – The Rfactor Inte...
(Date:11/25/2009)...ERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-- On...dthatthecompanywillhosttwoinvestoreventsinDecember...0a.m.CT/10:00a.m.ET ,, Principalinvestigators...inrelapsedand/orrefractorymultiplemyeloma,asfeatur...eetingandExpositioninNewOrleans,LA.Theteleconferen...
(Date:11/25/2009)...LVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anar...forDrugEvaluationandResearch,titled"ADifficultBala...theNov.26,2009issueofTheNewEnglandJournalofMedicin...h/20090824/FDALOGO ) ,, Inthearticle,Woodcockdi...inmedicationforthosewhoneeditandmanagingtheriskspo...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
... Using a technology that can quickly screen all 20...entists have isolated 87 genes that seem to affect...hemotherapy drugs.// In a study available on...all RNA molecules – the first used by a university...
... Prolonged hypogonadism may result in erectile dys...mory loss, bone mineral loss, and the metabolic sy...el is well-known for its association with osteopor...the Archives of Internal Medicine, Orwoll and coll...
... Doctors should not shy away from writing letters ...es, according to an article in the latest Medical ...litigious society, some doctors may be wary of pen... 'Letters can be dangerous in the hands of ...
... Bovine TB is scary because it can also spread to ...ollowing reports of six human cases in England,// ...The Health Protection Agency has stressed the need... cases had a common factor. The spread was caused ...
... The AMA welcomes the COAG decision to adopt much ...ational health professional boards// to run regist...he nine health professions. AMA President, D...istent standards for registration and professional...
... In a new study, researchers from the Harvard Scho...health outcomes of control and eradication options... costs of global polio eradication will ultimately...ren, is a highly infectious viral disease that can...
Other Medicine News:Health News:Gene Screening Points Way to More Effective Chemotherapy 2Health News:Low Serum Testosterone Levels Associated With Fall Risk in Elderly Men 2Health News:COAG Gets It Mostly Right On National Registration 2Health News:Eradicating Polio a Better Option Than Control of the Disease: Study 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: